Image-Guided Minimally Invasive Spinal Decompression for Spinal Stenosis
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This draft policy governs coverage determinations for percutaneous image-guided minimally invasive lumbar decompression (mild®) targeting central spinal stenosis, specifying distinctions for Medicare Advantage and Commercial products and addressing HCPCS code G0276 for Medicare and commercial contexts.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medicare Advantage Plans coverage
Covered only as part of a CMS-approved Coverage with Evidence Development (CED) clinical trial when performed as a blinded PILD or placebo-control:
HCPCS G0276 may be covered; claims must include appropriate Q0/Q1 modifiers
Commercial Products stance
Commercial coverage determination based on evidence:
G0276 listed as not medically necessary for Commercial Products
Evidence summary and general coverage implication
Available clinical evidence and conclusion:
Policy concludes evidence insufficient to establish efficacy for commercial use; well-designed trials with relevant control groups are needed
The percutaneous image-guided minimally invasive lumbar decompression (mild®) procedure is intended to treat central lumbar spinal stenosis only. The procedure uses a fluoroscopically guided cannula and single‑use instruments to resect hypertrophied ligamentum flavum and small laminar bone fragments to decompress the central canal. The device and technique are not intended for disc procedures and are contraindicated for use near lateral neural elements, as the instruments remain dorsal to the dura and cannot address nerve root compression or disc herniation.
If services are determined to be not medically necessary or otherwise non‑covered under the member’s benefit plan, those services may be excluded from payment. Providers may not charge the member for non‑covered or not medically necessary services unless the member was informed and provided written agreement in advance to accept financial responsibility.
For Commercial Products, the blinded percutaneous image‑guided lumbar decompression procedure performed as part of a CMS Coverage with Evidence Development (CED) clinical trial (HCPCS G0276) is considered not medically necessary and will be denied for commercial members.
Services determined to be not medically necessary are not covered for payment. Providers should verify member benefits and obtain any required authorizations per the subscriber agreement; denial of payment may occur for not medically necessary services.
Coding
| G0276 | Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control, performed in an approved coverage with evidence development (CED) clinical trial |
| Q0 | Investigational clinical service provided in a clinical research study that is in an approved research study (Medicare claims filed without the Q0 modifier will deny as not medically necessary) |
| Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study |
| CMS NCD 150.13 | Percutaneous Image-guided Lumbar Decompression for Lumbar Spinal Stenosis (national coverage determination reference) |
Provider Actions & Billing
Medical Criteria / Prior Authorization
Not applicable
Benefit Verification
Benefits may vary by contract. Refer to the member's Benefit Booklet, Evidence of Coverage, or Subscriber Agreement for applicable benefits, coverage limitations, and whether services are considered not medically necessary or non-covered.
Prior Authorization & Benefits
Prior authorization: Not applicable for this policy. Individual plan requirements may differ; verify prior authorization requirements through the member's benefit documents or by contacting the provider call center.
Billing/Coding for CMS-Approved Clinical Studies (Medicare Advantage)
For Medicare Advantage members treated within a CMS-approved Coverage with Evidence Development (CED) clinical study, bill G0276 when appropriate and include the correct modifier: Q0 for investigational clinical service provided in an approved research study or Q1 for routine clinical service provided in an approved research study. Follow CMS billing rules for Medicare Advantage claims.
- HCPCS G0276 — Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control (Medicare CED only)
- Use Modifier Q0 for investigational clinical service
- Use Modifier Q1 for routine clinical service
Commercial Products — Not Medically Necessary
For Commercial Products, HCPCS code G0276 (blinded PILD/placebo in a CED trial) is considered not medically necessary and is non-covered. Claims for services determined to be not medically necessary or non-covered may be denied and the provider may not bill the member unless the member was informed and provided written agreement to pay in advance.
- Commercial: G0276 — Not medically necessary / Non-covered
Provider Actions
Provider actions: Benefits and eligibility are determined by the member's subscriber agreement, member certificate, and/or employer agreement. For member-specific benefits or prior authorization assistance, contact the BCBSRI provider call center. Do not bill members for services determined to be not medically necessary or non-covered unless prior written consent was obtained per the provider participation agreement.
Background
Lumbar spinal stenosis (LSS) is a narrowing of the central spinal canal that compresses the spinal cord and nerve roots, commonly producing neurogenic claudication—leg pain, heaviness, or weakness brought on by standing or walking and relieved by sitting or spinal flexion. Conventional posterior decompressive surgeries (eg, laminectomy, laminotomy) are established treatments; the mild® procedure is an ultra‑minimally invasive, percutaneous, fluoroscopically guided decompression that targets hypertrophied ligamentum flavum to enlarge the central canal while avoiding open surgical exposure. Benefit and eligibility are determined by the member’s subscriber agreement, and this policy does not guarantee payment.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.